Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Total Non-Current Liabilities (2021 - 2025)

INVO Fertility (IVF) has disclosed Total Non-Current Liabilities for 5 consecutive years, with $12.2 million as the latest value for Q3 2025.

  • Quarterly Total Non-Current Liabilities rose 9800.44% to $12.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $12.2 million through Sep 2025, up 9800.44% year-over-year, with the annual reading at $21.2 million for FY2024, 17163.7% up from the prior year.
  • Total Non-Current Liabilities for Q3 2025 was $12.2 million at INVO Fertility, down from $15.6 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $21.9 million in Q1 2025, with the low at $107374.0 in Q4 2022.
  • Average Total Non-Current Liabilities over 5 years is $4.5 million, with a median of $132690.5 recorded in 2021.
  • The sharpest move saw Total Non-Current Liabilities fell 24.56% in 2022, then surged 17720.43% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $142321.0 in 2021, then dropped by 24.56% to $107374.0 in 2022, then grew by 14.61% to $123060.0 in 2023, then skyrocketed by 17163.7% to $21.2 million in 2024, then plummeted by 42.65% to $12.2 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $12.2 million, $15.6 million, and $21.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.